Investing

Day One Biopharma : DAWN

DAWN

Stock Data

$21.53

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Day One Biopharmaceuticals is a pioneering company focused on creating targeted therapies for individuals with genetically specific cancers. At the forefront of their innovative pipeline is tovorafenib, a promising treatment designed to penetrate the brain and combat pediatric low-grade glioma in its advanced trial stages. Additionally, they are developing Pimasertib, aimed at inhibiting key cancer growth pathways. Founded in 2018 and based in Brisbane, California, Day One is committed to transforming cancer treatment for patients with critical needs.

All Day One Biopharma Articles

2 Articles

Lee Jackson | Mar 11, 2026 at 7:45 AM EDT

Here Are Wednesday’s Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More

Pre-Market Stock Futures: Futures are trading lower as we hit the mid-point of the trading week, and while we didn’t…

Lee Jackson | Mar 10, 2026 at 8:06 AM EDT

Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe’s, Qualcomm, Rivian, Strategy and More

Pre-Market Stock Futures: Futures are trading lower as many across Wall Street breathed a semi-sigh of relief yesterday after oil…